← Back to Clinical Trials
Recruiting NCT07098845

NCT07098845 Mindfulness-Based Intervention With a Supplement for Stress-Related Problems in College Students Across Multiple Sites (4SITE)

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07098845
Status Recruiting
Phase
Sponsor Colorado State University
Condition Stress
Study Type INTERVENTIONAL
Enrollment 120 participants
Start Date 2025-09-01
Primary Completion 2026-05

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 25 Years
Study Type INTERVENTIONAL
Interventions
Learning to BREATHELearning to BREATHE PlusHealthEd

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 120 participants in total. It began in 2025-09-01 with a primary completion date of 2026-05.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The investigators hope to add to the feasible, acceptable, and effective interventions that offer reductions in depression, anxiety, and stress for students at U.S. colleges and universities, the majority of whom experience mental health problems but the minority of whom who receive adequate mental health support. By studying the extent to which a multi-modal supplement boosts effects for a mindfulness-based intervention (and comparing both to an active health education control program) to reduce depression, anxiety, and stress, the proposed research seeks to rigorously investigate complementary and integrative health interventions and their roles in improving health.

Eligibility Criteria

Inclusion Criteria: * aged 18-25 years * enrolled in a college or university * experiencing elevated stress * plan to be available in-person in the semester following the study * own a smart phone. Exclusion Criteria: * have several depressive symptoms * have suicidal ideation.

Contact & Investigator

Central Contact

Rachel Lucas-Thompson, PhD

✉ lucas-thompson.rachel.graham@colostate.edu

📞 970-491-5718

Principal Investigator

Rachel Lucas-Thompson, Dr.

PRINCIPAL INVESTIGATOR

Colorado State University

Frequently Asked Questions

Who can join the NCT07098845 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 25 Years, studying Stress. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07098845 currently recruiting?

Yes, NCT07098845 is actively recruiting participants. Contact the research team at lucas-thompson.rachel.graham@colostate.edu for enrollment information.

Where is the NCT07098845 trial being conducted?

This trial is being conducted at Denver, United States, Fort Collins, United States, Saint Paul, United States, Saint Paul, United States.

Who is sponsoring the NCT07098845 clinical trial?

NCT07098845 is sponsored by Colorado State University. The principal investigator is Rachel Lucas-Thompson, Dr. at Colorado State University. The trial plans to enroll 120 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology